Biggest News Aggregation in the World
📰 Looking Statement News

Page 28 - Looking Statement News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Looking Statement. Real-time updates on events, politics, business and more.

Merck Receives Positive EU CHMP Opinion for KEYTRUDA® (pembrolizumab) Plus Trastuzumab and Chemotherapy as First-Line Treatment for HER2-Positive Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma Expressing PD-L1 (CPS ≥1)

Opinion granted based on positive progression-free survival results from the Phase 3 KEYNOTE-811 trial If approved, KEYTRUDA would be the first immunotherapy for the first-line treatment of...
United States Scot Ebbinghaus European Union Merck Research Laboratories Statement Of Merck Co Inc Merck Co Inc

Merck Announces Phase 3 KEYNOTE-A18 Trial Met Primary Endpoint of Progression-Free Survival (PFS) in Patients With Newly Diagnosed High-Risk Locally Advanced Cervical Cancer

KEYTRUDA® (pembrolizumab) plus concurrent chemoradiotherapy demonstrated statistically significant and clinically meaningful improvement in PFS versus concurrent chemoradiotherapy alone in these patients
United States Domenica Lorusso Gursel Aktan European Network For Gynaecological Oncology Trial Foundation Inc Exchange Commission

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science